newsfilter
← Latest News
Business Wire·

SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024

Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December